Atgenomix
PrivateLast Round
Series A
Jan 30, 2020
Total Funding Raised
$2.7M
Company Overview
Atgenomix operates in Healthcare & Life Sciences and is based in Taipei. Its latest recorded funding round was a Series A round in January 2020.
Atgenomix is a healthcare technology company that provides a cloud-based biomedical informatics platform to empower clinical laboratories and researchers to manage and analyze large-scale genomic data for precision medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Cloud Infrastructure, Platform-as-a-Service
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atgenomix Comparables
Compare Atgenomix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DNAnexus | 81% | |
| LatchBio | 81% | |
| Lifebit | 77% |
For institutional investors. Book with your work email.
Atgenomix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 30, 2020 | ||||
| Accelerator | Apr 22, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Atgenomix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Darwin Venture Management | Series A |
| TransLink Capital | Series A |
| Darwin Venture Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 14, 2025
Monthly visitors grew 125% MoM, reaching 1.3K.
- Jan 30, 2020
$3M round led by Darwin Venture Management and TransLink Capital.
For institutional investors. Book with your work email.
Atgenomix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Atgenomix's valuation, stock price, and market status.
Is Atgenomix a public or private company?
Atgenomix is a private company.
What is the current stock price of Atgenomix?
Atgenomix is a private company, so its shares have no public market price. Caplight tracks Atgenomix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Atgenomix worth (valuation)?
Valuation information for Atgenomix is not publicly available.
Can I buy Atgenomix stock?
Atgenomix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Atgenomix's last funding round?
Atgenomix's most recent funding round was Series A on January 30, 2020.
Who are the main investors in Atgenomix?
Key investors in Atgenomix include Darwin Venture Management, TransLink Capital, Darwin Venture Management.
Will Atgenomix IPO soon?
No public IPO plans have been announced for Atgenomix.
How can I track Atgenomix secondary market activity?
Caplight tracks bids, offers, and trades in Atgenomix's shares on secondary markets.